Features of impact of hyperferritinemia in combination with hyperuricemia on the course of gout.

Authors

DOI:

https://doi.org/10.26641/2307-0404.2020.1.200414

Keywords:

gout, hyperferritinemia, arterial hypertension, ferritin, blood uric acid, iron metabolism

Abstract

The purpose of the study is to find out the frequency of development of hyperfer­ritinemia in combination with hyperuricemia in patients with gout, to assess their pathogenetic significance and to outline their role in the development of joint syndrome, to identify informative prognostic criteria. 72 patients with gout were examined. The 1st (main) group included 37 patients with gout with hyperuricemia combined with hyper­ferritinemia, whose mean age (SD) was 55.9 (10.7) years. Group 2 (comparison group) included 35 patients with gout and hyperuricemia and normal levels of ferritin (mean age - 52.8 (4.8) years). Group 3 (control) group included 20 practically healthy individuals (mean age 52.0 (2.9) years). The average level of blood uric acid was significantly dif­ferent (p=0.0254) in the main group and the comparison group and amounted to 464.5 (122.5) μmol/L and 403.8 (403.8; 403.8), respectively. The value of ferritin in the main group was significantly higher 410.2 (356.2; 415.2), p<0.01) ng/mL, than in the comparison group (132.1 (20.5) ng/mL, as well as the values of the urine uric acid and C-reactive protein values (hs-CRP) (p=0.0001) 8.2 (6.0; 8.2) and 5.8 (6.1) mg/L, respectively. A direct reliable cor­relation was established (r=0.30; p<0.05) between the level of blood uric acid and ferritin, the duration of gout (r=0.41; p<0.05), the total number of affected joints (r=0.35; p<0.03), the severity of gout (r=0.36; p<0.05), as well as between the level of ferritin and the number of exacerbations of gout (r=0.44; p<0.05). Hyperferritinemia in com­bination with hyperuricemia is found in 51.0% of patients with gout, significantly worsening the course of the inflammatory process Patients with gout and high levels of ferritin, unlike patients with normal levels of ferritin, have the following clinical anamnestic signs: greater number of exacerbations of gout per year, duration of gout and last outbreak of gout, exacerbation of arthritis, total number of affected joints, pain intensity during exacerbation by scale VAS. In patients with gout, the severity of the course and the form of gouty arthritis, which are determined according to imaging methods (erosion, peripheral and bone tophus, the sign of "double contour", the degree of narrowing of the joint gaps and the severity of subchondral sclerosis), have prognostic significance. The association of ferritin with blood uric acid in gout does not depend on the level of hs-CRP.

Author Biographies

G. P. Kuzmina

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of therapy, cardiology and family medicine
30-richchia Peremohy str., 2, Kryvyi Rig, 50056, Dnipropetrovsk Region, Ukraine 

O. M. Lazarenko

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of therapy, cardiology and family medicine
30-richchia Peremohy str., 2, Kryvyi Rig, 50056, Dnipropetrovsk Region, Ukraine 

References

Kondratjuk VJe, Tarasenko OM. [A modern look at the pathogenetic aspects of gout (literature review)]. Ukrainskyi revmatologichnyi zhurnal. 2018;74(4):32-37. Ukrainian.

[Order of the Ministry of Health of Ukraine of May 24, 2012 No. 384 «On approval and implementation of medical and technological documents on stan­dardization of medical care for arterial hypertension»]; 2012. Ukrainian.

[Recommendations of the Ukrainian Association of Cardiology for the Prevention and Treatment of Hyper­tension. Manual to the National Program for the Preven­tion and Treatment of Hypertension]. Kyiv: PP VMB; 2008. p. 80. Ukrainian.

Shuba NM. [Hyperuricemia is a multimorbid pathology]. Ukrainskyi revmatologichnyi zhurnal. 2015;1(59):72-83. Russian.

Fatima T, Merriman T, Iverson C, Miner JN. AB0830 Iron Metabolism: Association of Ferritin with Serum Urate and Gout. Ann. Rheum. Dis. 2016;75:1187. doi: http://dx.doi.org/10.1136/annrheumdis-2016-eular.2981

Aiguo M, Jingyan W, Zhang Н, Dayong Wu. Ana­lysis of Serum Ferritin and High Sensitive C Reactive Protein in Patients with Gout. FASEB J. 2017;31(1):lb414.

Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016. Arthritis Rheumatol. 2019;71(6):991-9. doi: https://doi.org/10.1002/art.40807

Kuo CF, Grainge MJ, See LC, et al. Epidemio­logy and management of gout in Taiwan: a nationwide population study. Arthritis Res. Ther. 2016;23(17):13-19. doi: https://doi.org/10.1186/s13075-015-0522-8

Zhang YN, Xu C, Xu L, et al. High serum ferritin levels increase the risk of hyperuricemia: a cross-sectional and longitudinal study. Ann. Nutr. Metab. 2014;64(1):6-12. doi: https://doi.org/10.1159/000358337

Flais J, Bardou-Jacquet E, Deugnier Y, et al. Hy­per­ferritinemia increases the risk of hyperuricemia in HFE-here­ditary hemochromatosis. Joint Bone Spine. 2017;84 (3):293-7. doi: https://doi.org/10.1016/j.jbspin.2016.05.020

Richette P, Latourte A. Hyperferritinaemia and hyperuricaemia – a causal connection? Nat. Rev. Rheumatol. 2018;14(11):628-9. doi: https://doi.org/10.1038/s41584-018-0100-y

Neogi T, Jansen T, Dalbeth N, et al. 2015 Gout Classification Criteria. An American College of Rheuma­tology/European League Against Rheumatism Colla­borative Initiative Arthritis. Rheumatology. 2015;67(10):2557-68. doi: https://doi.org/10.1002/art.39254

Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018;39(33):3021-104. doi: https://doi.org/10.1093/eurheartj/ehy339

Fatima T, McKinney C, Major TJ, et al. The relationship between ferritin and urate levels and risk of gout. Arthritis Res. Ther. 2018;20:179. doi: https://doi.org/10.1186/s13075-018-1668-y

Oda K, Kikuchi E, Kuroda E, et al. Uric acid, ferritin and γ-glutamyltransferase can be informative in prediction of the oxidative stress. J. Clin. Biochem. Nutr. 2019;64(2):124-8. doi: https://doi.org/10.3164/jcbn.18-23

Downloads

Published

2020-04-09

How to Cite

1.
Kuzmina GP, Lazarenko OM. Features of impact of hyperferritinemia in combination with hyperuricemia on the course of gout. Med. perspekt. [Internet]. 2020Apr.9 [cited 2024Apr.24];25(1):141-9. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/200414

Issue

Section

CLINICAL MEDICINE